FR2168137A1 - Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities - Google Patents

Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities

Info

Publication number
FR2168137A1
FR2168137A1 FR7201439A FR7201439A FR2168137A1 FR 2168137 A1 FR2168137 A1 FR 2168137A1 FR 7201439 A FR7201439 A FR 7201439A FR 7201439 A FR7201439 A FR 7201439A FR 2168137 A1 FR2168137 A1 FR 2168137A1
Authority
FR
France
Prior art keywords
opt
bis
lower alkyl
substd
hydrocarbylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7201439A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynachim SARL
Original Assignee
Dynachim SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynachim SARL filed Critical Dynachim SARL
Priority to FR7201439A priority Critical patent/FR2168137A1/fr
Publication of FR2168137A1 publication Critical patent/FR2168137A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FR7201439A 1972-01-17 1972-01-17 Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities Withdrawn FR2168137A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7201439A FR2168137A1 (en) 1972-01-17 1972-01-17 Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7201439A FR2168137A1 (en) 1972-01-17 1972-01-17 Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities

Publications (1)

Publication Number Publication Date
FR2168137A1 true FR2168137A1 (en) 1973-08-31

Family

ID=9092001

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7201439A Withdrawn FR2168137A1 (en) 1972-01-17 1972-01-17 Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities

Country Status (1)

Country Link
FR (1) FR2168137A1 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0637959A1 (fr) * 1992-04-30 1995-02-15 The Regents Of The University Of California Analogues solubles de probucol
US6121319A (en) * 1997-05-14 2000-09-19 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
WO2004062622A2 (fr) 2003-01-13 2004-07-29 Atherogenics, Inc. Procede de preparation d'esters et d'ethers de probucol et ses derives
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US6887712B1 (en) 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US6960683B2 (en) 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7071158B2 (en) 1997-07-01 2006-07-04 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US7166605B2 (en) 2002-03-22 2007-01-23 Nicox, S.A. Probucol nitro-derivatives
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US7294737B2 (en) 2004-04-20 2007-11-13 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
WO2008118948A1 (fr) 2007-03-26 2008-10-02 Atherogenics, Inc. Procédés et compositions de dérivés de probucol pour le traitement du diabète
US7687659B2 (en) 2005-04-21 2010-03-30 Salutria Pharmaceuticals Llc Process for the separation of probucol derivatives
US7897776B2 (en) 2007-04-23 2011-03-01 Salutria Pharmaceuticals Llc Sulfonamide containing compounds for treatment of inflammatory disorders

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161946A3 (fr) * 1992-04-30 2003-12-10 AtheroGenics, Inc. Analogues solubles du Probucol
EP0637959A4 (fr) * 1992-04-30 1995-03-29 Univ California Analogues solubles de probucol.
EP0637959A1 (fr) * 1992-04-30 1995-02-15 The Regents Of The University Of California Analogues solubles de probucol
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6828447B2 (en) 1997-05-14 2004-12-07 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6602914B2 (en) 1997-05-14 2003-08-05 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6617352B2 (en) 1997-05-14 2003-09-09 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6147250A (en) * 1997-05-14 2000-11-14 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US7189870B2 (en) 1997-05-14 2007-03-13 Atherogenic, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US7375252B2 (en) 1997-05-14 2008-05-20 Atherogenics, Inc. Compounds and method for the inhibition of the expression of VCAM-1
US6548699B1 (en) 1997-05-14 2003-04-15 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US7087645B2 (en) 1997-05-14 2006-08-08 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6121319A (en) * 1997-05-14 2000-09-19 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US7071158B2 (en) 1997-07-01 2006-07-04 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6887712B1 (en) 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US7183317B2 (en) 2000-04-11 2007-02-27 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US7166605B2 (en) 2002-03-22 2007-01-23 Nicox, S.A. Probucol nitro-derivatives
US6960683B2 (en) 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7371895B2 (en) 2002-07-12 2008-05-13 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7273948B2 (en) 2003-01-13 2007-09-25 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
WO2004062622A2 (fr) 2003-01-13 2004-07-29 Atherogenics, Inc. Procede de preparation d'esters et d'ethers de probucol et ses derives
US7622604B2 (en) 2003-01-13 2009-11-24 Salutria Pharmaceuticals Llc Process of preparing esters and ethers of probucol and derivatives thereof
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US7294737B2 (en) 2004-04-20 2007-11-13 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7687659B2 (en) 2005-04-21 2010-03-30 Salutria Pharmaceuticals Llc Process for the separation of probucol derivatives
WO2008118948A1 (fr) 2007-03-26 2008-10-02 Atherogenics, Inc. Procédés et compositions de dérivés de probucol pour le traitement du diabète
US8252840B2 (en) 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
US7897776B2 (en) 2007-04-23 2011-03-01 Salutria Pharmaceuticals Llc Sulfonamide containing compounds for treatment of inflammatory disorders

Similar Documents

Publication Publication Date Title
FR2168137A1 (en) Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities
GB1098112A (en) Phenoxy substituted 3-hydroxyalkanoic acids and alkyl esters thereof
IL58671A (en) Phosphorus-containing cyanohydrine derivatives and process for the preparation thereof
GB1367207A (en) Polyacrylates of n-hetercyclic componds,processes for their manu facture and use
GB1416116A (en) Distyryl-benzene derivatives their manufacture and their use
GB1164743A (en) Basic Anthraquinone Dyes, their production and use
ES409488A1 (es) Procedimiento para la preparacion de derivados de triazoli-lorganofosforo.
FR2130975A5 (en) Bis(4-(phenoxyalkanoyloxy)-phenylthio)alkanes - hypolipemics hypocholesterolemics
SE7508607L (sv) Nya foreningar och forfarnde for framstellning av dessa
GB1189848A (en) Organometallic Aminooxy Compounds
FR1472490A (fr) Procédé d'oxydation du noir de carbone par un agent oxydant azoté
GB1317549A (en) Bis-2,3-dihaloalkyl-2-cyanoalkylphosphonates
ES313850A1 (es) Procedimiento para preparar acidos carboxilicos por oxidacion.
GB1077114A (en) Process for the production of 7-amino-3-phenyl-coumarin compounds
FR2168139A1 (en) N-acyl morpholines - with hypocholesterolaemic and anorectic activity
ES350544A1 (es) Procedimiento para el aclarado optico de masas fundidas hi-lables.
GB1119378A (en) Dibenzocycloheptene derivatives
ES314246A1 (es) El procedimiento para la preparacion de nuevos carbamatos den-benzodioxilo.
ES378791A1 (es) Un procedimiento de preparar nuevos tiofosfitos y tiofosfa-tos organicos.
GB1479748A (en) Production of 2,1,3-benzothiadiazin-4-one-2,2-dioxides
GB1131941A (en) Improvements in or relating to substituted malonic acid hydrazides
ES430076A1 (es) Procedimiento para la obtencion de 4-oxa-5-hidroxi-polici- cloalquenonas-(3).
GB1092134A (en) Production of carbamyl halides
GB1107866A (en) Alkylidene acetic acid derivatives
FR1604880A (en) 2-aminoindano (2,1-d) oxazolines - with hypocholesterolaemic and anorectic activityl salt

Legal Events

Date Code Title Description
ST Notification of lapse